Christine Borowski
Senior Associate @ Access Biotechnology
New York, United States
Christine Borowski is a Series B investor at Access Biotechnology in New York focused on Biotechnology and Medical. Christine Borowski is the Senior Associate at Access Biotechnology.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Christine Borowski invests in
Stages Christine Borowski invests in
Countries Christine Borowski invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Health Care 1 (33%)
- Life Science 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Series B 2 (67%)
- Series C 1 (33%)
Country
- Denmark 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hemab
|
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threateningcomplications. | $157M / Series C / Oct 27, 2025 | |
Santa Ana Bio
|
Santa Ana Bio is a biotechnology company that leverages deep cell profiling technologies to design precision biologics in the autoimmune space. The company was founded in 2021 and is headquartered in Alameda, California. | $125M / Series B / Jun 13, 2024 | |
|
Hemab
|
Hemab is a company that creates preventative treatments for bleeding and thrombosis problems. The medicines developed by the business aggregate modify, balance, and at times recruit endogenous clotting components already present in the blood to the site of injury, allowing patients to produce hemostatic plugs or clots to avert life-threateningcomplications. | $135M / Series B / Feb 21, 2023 |
Co-Investors
About Access Biotechnology
Access Biotechnology is the life science investment arm of Access Industries. They invest in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. They invest in both private and public biopharma companies across therapeutic areas, modalities, and development stages – fromdiscovery-stage technology platforms to late-stage clinical programs.The company is based in New York.
Access Biotechnology Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christine Borowski
Senior Associate
|
|||
Dan Becker
Principal
|
|||
Jeffrey Ives
Advisor
|
|||
Liam Ratcliffe
Head of Biotechnology
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Christine Borowski invest in?
Christine Borowski invests primarily in Biotechnology, Medical and Health Care startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Christine Borowski?
Public channels for Christine Borowski include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Christine Borowski last invest?
The most recent investment recorded for Christine Borowski closed in Oct 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
